Physician profile
Grace Braimoh
NPI 1497240840
$2,130.40
in general payments reported to CMS, 2019-2025
12 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $222 · 2023: $484 · 2024: $751 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $637.93 | 2022-2025 | Axios, Resolution 360 Clip, General - Metal Stents - G.I. |
| Abbvie INC. | $433.88 | 2021-2025 | Mavyret |
| Medtronic, INC. | $315.27 | 2023-2024 | Endoflip |
| Fujifilm Healthcare Americas Corporation | $138.35 | 2025 | |
| Phathom Pharmaceuticals, INC. | $131.28 | 2025 | Voquezna |
| Cook Medical LLC | $126.86 | 2023 | Hemospray |
| Janssen Biotech, INC. | $125.73 | 2024 | Tremfya, Stelara |
| Erbe USA INC | $84.89 | 2023 | Erbe Vio3 |
| Genzyme Corporation | $40.55 | 2025 | |
| Madrigal Pharmaceuticals | $39.09 | 2025 | Rezdiffra |
| Olympus America INC. | $35.77 | 2024 | Evis Eus Endoscopic Ultrasound Center |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.80 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Braimoh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.